FDA Import Holds and Detentions: How to Respond and Avoid Losing Your Shipment (2026)
By Tam Nguyen | CEO, GOL Solution | 24+ years in international trade & cross-border logistics
Last Updated: August 2026
An FDA import detention happens when U.S. Customs and Border Protection, acting on the FDA’s behalf, stops a shipment at the port of entry because the FDA has reasonable grounds to suspect it violates U.S. law. The detention itself is not a final decision. It is a hold that gives the importer a limited window to prove the product is compliant before the FDA moves to a formal refusal.
For businesses exporting food, cosmetics, dietary supplements, or medical devices to the U.S., a detention is usually the first sign that something in the compliance chain, often FSVP, labeling, or facility registration, was incomplete before the shipment left origin. This guide covers what triggers a detention, what the notice actually requires of you, and the response window that determines whether your shipment clears or gets refused.
What Is an FDA Import Detention?
An FDA detention occurs when a shipment entering the United States is held because the FDA has reasonable grounds to suspect it does not comply with U.S. law. The FDA does not need to test or physically examine the product to detain it. Evidence from a prior shipment, a facility inspection, or a pattern of noncompliance at the manufacturer is sufficient.
Common triggers include:
- Adulteration or contamination of the product
- Mislabeling or misbranding, including unapproved claims
- Manufacturing, processing, or packing under unsanitary conditions
- Missing or incomplete FSVP documentation for the importer of record
- A manufacturer or product line already listed on an FDA Import Alert
A large share of detentions trace back to the FDA’s Import Alert list. Firms with a documented pattern of noncompliance are placed on Detention Without Physical Examination (DWPE), meaning every shipment from that firm is detained automatically at the border until the firm demonstrates compliance across five consecutive clean shipments.
GOL Insight
A dietary supplement client came to us mid-crisis: their product had FDA registration through another vendor, but no FSVP importer was on file for the shipment. Without an FSVP importer, the FDA would reject the import outright, and the cost of returning the cargo to origin would have exceeded the value of the shipment. Destruction was the likely outcome.
Our team built the full FSVP compliance scope in 5 days: supplier audit, FSVP plan development, and Letter of Consent issuance. That was enough to clear the shipment and avoid both destruction and mounting storage and detention costs.
The root cause in most detention cases we see is not a determined violation. It is a missing piece of the compliance chain, most often FSVP, that nobody flagged until the shipment was already at the port.
The Detention Notice and Your Response Window
When the FDA detains a shipment, it issues a Notice of FDA Action, Detention (commonly called a Notice of Detention and Hearing) to the importer, owner, consignee, and customs broker. The notice specifies the alleged violation, cites the relevant law, and sets a respond-by date.
The respond-by date typically allows 10 business days from the date of detention, though the notice often states a 20-calendar-day window to account for weekends, holidays, and mail time. During this window, the owner or consignee has the right to a hearing and can submit testimony, meaning evidence, lab results, or a corrective action plan, to refute the alleged violation.
Key Deadlines at a Glance
| Stage | Typical Timeframe |
|---|---|
| Detention Notice issued | At the time of detention |
| Respond-by date (testimony or hearing request) | 10 business days (up to 20 calendar days) |
| Extension request | Must be submitted before the respond-by date |
| Refusal Notice (if no adequate response) | Issued after the respond-by date passes |
| Export or destruction of refused product | Within 90 days of refusal |
If the owner or consignee does not respond adequately by the deadline, the FDA issues a Notice of FDA Action, Refusal, denying the product admission into the United States. At that point the only options are exporting the product out of the U.S. or destroying it, both within 90 days of the refusal notice.
How to Respond to a Detention Notice
Step 1: Read the notice in full immediately
The notice specifies the exact charge (adulteration, misbranding, etc.) and the section of law cited. Everything downstream depends on identifying the correct violation before you respond.
Step 2: Confirm your response deadline and request an extension if needed
Extension requests must go to the FDA compliance officer named on the notice, before the original deadline passes, with a reasonable basis for the delay.
Step 3: Build your testimony
Testimony is any evidence submitted to refute the violation: lab results, a corrective action plan, or documentation proving the shipment does not match the alleged issue. For a labeling violation, this might mean a corrected label. For a contamination concern, it means third-party lab testing against the specific threshold cited.
Step 4: Coordinate testing or reconditioning
Work with a lab experienced in FDA detention procedures. If the product fails testing, reconditioning, such as sorting out damaged units, may bring it into compliance. If it cannot be brought into compliance, plan for export or destruction within the 90-day window.
Step 5: Submit and track
Submit the complete testimony package before the deadline and confirm receipt with the compliance officer. FDA may request additional information before making a final admissibility decision.
The Fastest Way to Avoid a Detention: FSVP Compliance
FDA product registration and FSVP compliance are two separate obligations, and confusing them is one of the most common causes of a detention we see. Registering a product with the FDA does not satisfy the Foreign Supplier Verification Program requirement for the importer of record. Every shipment needs both.
An FSVP importer must have a supplier verification program, evidence of supplier audits, and a Letter of Consent on file before the shipment arrives, not after. When that documentation is missing, the shipment is exposed to detention regardless of whether the product itself is compliant.
When This Guidance Does Not Apply
This response process covers standard FDA import detentions for food, cosmetics, dietary supplements, and most medical devices. It does not cover:
- Shipments detained under a specific Import Alert with DWPE status, where removal requires a separate petition process (see our Import Alert 99-32 guide)
- Products that turn out to be unapproved drugs, which follow a different and more restrictive review pathway
- Situations requiring accredited laboratory testing. GOL coordinates with FDA-recognized labs but does not perform testing in-house
Work With GOL on FDA Detention Response and FSVP Compliance
GOL Solution has supported businesses exporting to the U.S. for over 24 years, with teams in Singapore, Vietnam, and the United States. When a shipment is detained, our team reviews the notice, identifies the fastest compliant path to release, whether that’s testimony, reconditioning, or FSVP remediation, and coordinates directly with the FDA compliance officer on your behalf.
If your shipment is currently detained or you want to confirm your FSVP documentation is complete before your next shipment leaves origin, contact our team for an initial review.
What is an FDA import detention?
An FDA import detention is a hold placed on a shipment entering the United States when the FDA has reasonable grounds to suspect it violates U.S. law. U.S. Customs and Border Protection enforces the hold at the port of entry on the FDA’s behalf. The FDA does not need to physically examine or test the product to detain it, evidence from a prior shipment, a facility inspection, or a documented pattern of noncompliance is enough. Once detained, the FDA issues a Notice of Detention and Hearing to the importer, owner, consignee, and customs broker, naming the alleged violation, citing the section of law involved, and setting a deadline to respond. A detention is not a final decision. It is a window to submit evidence proving compliance before the FDA moves to a formal refusal, which blocks the product from entering the U.S. altogether and starts a 90-day clock to export or destroy it.
What is DWPE and the FDA Import Alert list?
Detention Without Physical Examination (DWPE) means a shipment is automatically detained at the border without the FDA needing to inspect or test it first. Firms end up on DWPE status through an Import Alert, a published list the FDA maintains based on a documented pattern of noncompliance from a specific manufacturer, product line, or country. Once listed, every shipment from that firm is detained on arrival until the firm proves compliance, typically by demonstrating five consecutive shipments that meet FDA safety and quality standards. Getting removed from an Import Alert requires a formal petition to the FDA, complete with corrective action evidence and, in inspection-related cases, a successful re-inspection. That process is a longer undertaking than responding to a single detention notice, and it can keep a firm locked out of the U.S. market for months or longer if not managed proactively.
How long do I have to respond to an FDA detention notice?
The FDA typically gives 10 business days from the date of detention to respond, though the Notice of FDA Action often states a 20-calendar-day window to account for weekends, holidays, and mail delivery time. Your response, called testimony, needs to include evidence refuting the alleged violation: lab results, a corrective action plan, or documentation showing the product doesn’t match the cited issue. If you need more time, request an extension from the FDA compliance officer named on the notice before the original deadline passes, with a clear reason for the delay and a realistic new timeframe. Missing the deadline without requesting an extension typically results in the FDA issuing a formal refusal of admission, at which point testimony is no longer an option and the shipment must be exported or destroyed.
What happens if I don’t respond to a detention notice in time?
If the FDA doesn’t receive adequate testimony by the respond-by date, the compliance officer issues a Notice of FDA Action, Refusal, formally denying the product entry into the United States. From there, the importer has 90 days to either export the product out of the U.S. or destroy it, and both options typically involve coordination with U.S. Customs and Border Protection along with added brokerage and logistics costs. Storage costs continue to accrue during this period, and for perishable or time-sensitive goods, the financial impact compounds quickly, sometimes exceeding the value of the shipment itself. A refusal also creates a compliance record the FDA references in future admissibility decisions for that importer or manufacturer, which can make subsequent shipments more likely to face scrutiny even after the immediate issue is resolved.
Can FSVP compliance help prevent an FDA import detention?
Yes. A significant share of detentions happen not because the product itself is unsafe, but because the FSVP importer of record is missing required documentation: a supplier audit, an FSVP plan, or a Letter of Consent. FDA product registration and FSVP compliance are separate requirements, and having one does not satisfy the other, a distinction that trips up many first-time exporters. When FSVP documentation isn’t in place before the shipment arrives, the product is exposed to detention regardless of its actual safety or quality, and assembling that documentation after a detention notice arrives is far more expensive and time-pressured than preparing it beforehand. Building FSVP compliance before shipping, rather than scrambling to assemble it after a detention notice arrives, is the most reliable way to keep shipments moving through U.S. ports without delay.
